Connection

Elisabeth Puchhammer-Stöckl to Humans

This is a "connection" page, showing publications Elisabeth Puchhammer-Stöckl has written about Humans.
Connection Strength

0.080
  1. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021 04; 137:104795.
    View in: PubMed
    Score: 0.007
  2. Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet Med. 2021 05; 23(5):963-967.
    View in: PubMed
    Score: 0.007
  3. Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 2020 11; 8(11):1154-1158.
    View in: PubMed
    Score: 0.007
  4. Association of Severe Influenza Virus Infections With CD226 (DNAM-1) Variants. J Infect Dis. 2019 08 30; 220(7):1162-1165.
    View in: PubMed
    Score: 0.007
  5. Torque Teno Virus as a Novel Biomarker Targeting the Efficacy of Immunosuppression After Lung Transplantation. J Infect Dis. 2018 11 05; 218(12):1922-1928.
    View in: PubMed
    Score: 0.006
  6. Temporal dynamics of the lung and plasma viromes in lung transplant recipients. PLoS One. 2018; 13(7):e0200428.
    View in: PubMed
    Score: 0.006
  7. NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation. J Infect Dis. 2018 02 14; 217(5):802-806.
    View in: PubMed
    Score: 0.006
  8. Human cytomegalovirus (HCMV) genotype populations in immunocompetent individuals during primary HCMV infection. J Clin Virol. 2010 Jun; 48(2):100-3.
    View in: PubMed
    Score: 0.004
  9. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes. Allergy. 2022 01; 77(1):230-242.
    View in: PubMed
    Score: 0.002
  10. RT-PCR based SARS-CoV-2 variant screening assays require careful quality control. J Clin Virol. 2021 Aug; 141:104905.
    View in: PubMed
    Score: 0.002
  11. The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria. Clin Chem Lab Med. 2021 09 27; 59(10):1735-1744.
    View in: PubMed
    Score: 0.002
  12. Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown. Sci Rep. 2021 05 12; 11(1):10158.
    View in: PubMed
    Score: 0.002
  13. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021 04 20; 59(5).
    View in: PubMed
    Score: 0.002
  14. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Sci Immunol. 2021 03 04; 6(57).
    View in: PubMed
    Score: 0.002
  15. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin Chem Lab Med. 2021 04 27; 59(5):987-994.
    View in: PubMed
    Score: 0.002
  16. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020 12 09; 12(573).
    View in: PubMed
    Score: 0.002
  17. Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 2021 Feb; 49(1):171-175.
    View in: PubMed
    Score: 0.002
  18. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. J Infect Dis. 2020 07 06; 222(3):362-366.
    View in: PubMed
    Score: 0.002
  19. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences. J Clin Virol. 2020 08; 129:104537.
    View in: PubMed
    Score: 0.002
  20. Successful management of the first reported case in Austria of COVID-19 with ARDS. Infection. 2020 Aug; 48(4):647-651.
    View in: PubMed
    Score: 0.002
  21. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect Dis. 2018 06 01; 18(1):251.
    View in: PubMed
    Score: 0.002
  22. Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study. Biol Blood Marrow Transplant. 2018 01; 24(1):194-199.
    View in: PubMed
    Score: 0.001
  23. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe. Clin Infect Dis. 2016 Mar 01; 62(5):655-663.
    View in: PubMed
    Score: 0.001
  24. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
    View in: PubMed
    Score: 0.001
  25. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr. 2006 Mar; 41(3):352-60.
    View in: PubMed
    Score: 0.001
  26. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol. 1992 Feb; 80(2):160-5.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.